Singapore markets close in 4 hours 3 minutes

Clovis Oncology, Inc. (CLVS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
4.1200-0.2300 (-5.29%)
At close: 4:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
31/12/2017
Total revenue
156,944
164,522
143,006
95,388
55,511
Cost of revenue
39,845
41,305
34,686
22,074
11,737
Gross profit
117,099
123,217
108,320
73,314
43,774
Operating expenses
Research development
220,376
257,707
292,586
231,347
142,498
Selling general and administrative
142,253
163,894
182,769
175,781
138,907
Total operating expenses
370,219
425,405
485,066
407,128
281,405
Operating income or loss
-253,120
-302,188
-376,746
-333,814
-237,631
Interest expense
28,505
23,491
16,547
13,183
10,428
Total other income/expenses net
-26,803
-37,063
-2,475
-20,404
-101,916
Income before tax
-310,938
-369,759
-398,626
-367,401
-349,975
Income tax expense
-580
-547
1,798
608
-3,578
Income from continuing operations
-310,358
-369,212
-400,424
-368,009
-346,397
Net income
-310,358
-369,212
-400,424
-368,009
-346,397
Net income available to common shareholders
-310,358
-369,212
-400,424
-368,009
-346,397
Basic EPS
-
-4.38
-7.43
-7.07
-7.36
Diluted EPS
-
-4.38
-7.43
-7.07
-7.36
Basic average shares
-
84,307
53,873
52,066
47,047
Diluted average shares
-
84,307
53,873
52,066
47,047
EBITDA
-
-338,070
-374,311
-349,617
-337,043